| Rick A Mcpheeters, DO | |
|
1830 Flower St, Bakersfield, CA 93305-4144 | |
| (661) 326-2000 | |
| Not Available |
| Full Name | Rick A Mcpheeters |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 28 Years |
| Location | 1830 Flower St, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467419341 | NPI | - | NPPES |
| 00AX70960 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 20A7096 (California) | Secondary |
| 207P00000X | Emergency Medicine | 20A7096 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kern Medical Center | Bakersfield, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kern County Hospital Authority | 4688964521 | 214 |
News Archive
Amidst growing concerns over the low uptake of flu shots in Europe, scientists from the Italian National Research Council and the Joint Research Centre, the European Commission's sciuence and knowledge service, confirm that vaccinations remain the best way forward when it comes to stopping the spread of infectious diseases.
The Michigan Legislature took its first steps Wednesday toward tackling a proposed overhaul of the state's largest health insurer, Blue Cross Blue Shield of Michigan. Senate Insurance Committee Chairman Joe Hune introduced bills that would end the nonprofit health insurer's tax-exempt status and align it with competitors.
Improvements to the diagnosis and screening of sleep apnea are critical to stroke prevention, according to new stroke care guidelines released today at the Canadian Stroke Congress.
Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin. In a supplement to the Journal of Alzheimer's Disease, investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the fourth quarter and year-ended December 31, 2013.
› Verified 8 days ago
| Entity Name | Kern County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623538 PECOS PAC ID: 4688964521 Enrollment ID: O20160915002690 |
News Archive
Amidst growing concerns over the low uptake of flu shots in Europe, scientists from the Italian National Research Council and the Joint Research Centre, the European Commission's sciuence and knowledge service, confirm that vaccinations remain the best way forward when it comes to stopping the spread of infectious diseases.
The Michigan Legislature took its first steps Wednesday toward tackling a proposed overhaul of the state's largest health insurer, Blue Cross Blue Shield of Michigan. Senate Insurance Committee Chairman Joe Hune introduced bills that would end the nonprofit health insurer's tax-exempt status and align it with competitors.
Improvements to the diagnosis and screening of sleep apnea are critical to stroke prevention, according to new stroke care guidelines released today at the Canadian Stroke Congress.
Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin. In a supplement to the Journal of Alzheimer's Disease, investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the fourth quarter and year-ended December 31, 2013.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rick A Mcpheeters, DO 8825 Chisholm Dr, Bakersfield, CA 93312-4432 Ph: () - | Rick A Mcpheeters, DO 1830 Flower St, Bakersfield, CA 93305-4144 Ph: (661) 326-2000 |
News Archive
Amidst growing concerns over the low uptake of flu shots in Europe, scientists from the Italian National Research Council and the Joint Research Centre, the European Commission's sciuence and knowledge service, confirm that vaccinations remain the best way forward when it comes to stopping the spread of infectious diseases.
The Michigan Legislature took its first steps Wednesday toward tackling a proposed overhaul of the state's largest health insurer, Blue Cross Blue Shield of Michigan. Senate Insurance Committee Chairman Joe Hune introduced bills that would end the nonprofit health insurer's tax-exempt status and align it with competitors.
Improvements to the diagnosis and screening of sleep apnea are critical to stroke prevention, according to new stroke care guidelines released today at the Canadian Stroke Congress.
Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin. In a supplement to the Journal of Alzheimer's Disease, investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the fourth quarter and year-ended December 31, 2013.
› Verified 8 days ago
Dr. Shannon K. Grant, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Old River Rd, Bakersfield, CA 93311 Phone: 661-663-6275 Fax: 661-326-8022 | |
Dr. Michael Darin Niedens, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1830 Flower St, Bakersfield, CA 93305 Phone: 661-326-2667 | |
Rick Daniel Ornum Figurasin, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2615 Chester Ave, Bakersfield, CA 93301 Phone: 661-869-6227 | |
Albert Ko, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9900 Stockdale Hwy, Suite 105, Bakersfield, CA 93311 Phone: 661-410-9500 | |
Lev Libet, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Trailer #2 Dept Of Emergency Medicine, Bakersfield, CA 93306 Phone: 661-326-2168 | |
Dr. Adria Elene Ottoboni, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 Fax: 661-326-2165 | |
Dr. John Eric Fortenberry, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Old River Rd, Bakersfield, CA 93311 Phone: 661-326-8021 Fax: 661-326-8022 |